Background Systemic vascular injury occurs in coronavirus disease 2019 (COVID-19)
patients; however, the underlying mechanisms remain unknown. Methods To clarify the role …

Background: Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to
both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from …

Objective: Whether endotheliopathy only mirrors coronavirus disease 2019 (COVID-19)
severity or plays an intrinsic role in microvascular thrombosis and organ failure remains …

Patients with coronavirus disease 2019 (COVID-19) who are critically ill develop vascular
complications characterized by thrombosis of small, medium, and large vessels. Dysfunction …

Beside the commonly described pulmonary expression of the coronavirus disease 2019
(COVID-19), major vascular events have been reported. The objective of this study was to …

Purpose Endothelial damage and angiogenesis are fundamental elements of
neovascularisation and fibrosis observed in patients with coronavirus disease 2019 (COVID …

Severe coronavirus disease-19 (COVID-19) is characterized by vascular inflammation and
thrombosis. We and others have proposed that the inflammatory response to coronavirus …

The molecular basis of the wide clinical heterogeneity of Coronavirus disease 2019 (COVID-
19) is still unknown. Matrix metalloproteinases (MMPs) may have a role in the lung damage …

Background: Rising data suggest that COVID-19 affects vascular endothelium while the
underlying mechanisms promoting COVID-19-associated endothelial dysfunction and …

Introduction Endothelial damage and thrombosis caused by COVID-19 may imperil
cardiovascular health. More than a year since the WHO declared COVID-19 pandemic …